Keyphrases
Carbonate
100%
Fibroblast Growth Factor 23 (FGF23)
100%
Chronic Kidney Disease Patients
100%
Normophosphatemia
100%
Phosphate
50%
Serum Calcium
50%
Placebo Groups
33%
Dyslipidemia
16%
High Prevalence
16%
Placebo
16%
Endocrinology
16%
Kidney Disease Progression
16%
Double-blind Randomized Controlled Trial
16%
Baseline Characteristics
16%
Vascular Calcification
16%
Disease-specific Mortality
16%
Median Level
16%
Serum Phosphate
16%
Chronic Kidney Disease Stage
16%
Moderate Chronic Kidney Disease
16%
Moderate Stage
16%
Serum Phosphorus
16%
Cardiomegaly
16%
Nephrology
16%
Medicine and Dentistry
Chronic Kidney Disease
100%
Aragonite
100%
Fibroblast Growth Factor 23
100%
Placebo
50%
Isotopes of Calcium
50%
Dyslipidemia
16%
Prevalence
16%
Disease Exacerbation
16%
Randomized Controlled Trial
16%
Endocrinology
16%
Blood Vessel Calcification
16%
Cardiomegaly
16%
Nephrology
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Calcium Carbonate
100%
Fibroblast Growth Factor 23
100%
Placebo
50%
Dyslipidemia
16%
Prevalence
16%
Randomized Controlled Trial
16%
Disease Exacerbation
16%
Blood Vessel Calcification
16%
Cardiomegaly
16%
Biochemistry, Genetics and Molecular Biology
Fibroblast Growth Factor 23
100%
Calcium Carbonate
100%
Phosphate Blood Level
66%
Calcium Blood Level
50%
Phosphate Urine Level
33%
Prevalence
16%
Dyslipidemia
16%
Randomized Controlled Trial
16%